Digital tools are becoming increasingly important across veterinary medicine, from clinical workflows to client communication and practice operations.
According to the announcement, New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1. The development is relevant because it reflects how animal health companies, service providers, and technology platforms are responding to changing expectations in veterinary care.
What Was Announced
PARSIPPANY, N.J.--( BUSINESS WIRE )-- Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against these resistant isolates.
As ML resistance continues to challenge heartworm prevention, veterinarians need data that differentiate products at their labeled dosages to better inform their clinical decisions. 1 In the study, 24 dogs were experimentally challenged with the drug-resistant heartworm isolate (ZoeLA) and then given one of the two products or a negative control every month for six months at the standard labeled dosage.
Why This Matters for Veterinary Professionals
For veterinary professionals, technology announcements matter when they affect efficiency, access to care, diagnostics, reimbursement, or the daily workflow of the clinic.
At the practice level, the most relevant question is whether the development can reduce administrative friction, improve access to information, or support more consistent communication between veterinary teams and clients.
Industry Perspective
The animal health industry continues to move toward more connected, data-driven services for veterinary practices and pet owners.
While individual announcements should be interpreted in the context of their source, they can help veterinary professionals monitor where investment, innovation, and market attention are moving across the animal health sector.
Original announcement: The most frequently — https://www.businesswire.com/news/home/20261005782418/en/New-Peer-Reviewed-Publication-on-Laboratory-Study-That-Demonstrated-Simparica-Trio-Protected-3x-More-Dogs-From-Infection-With-a-Resistant-Heartworm-Isolate-Than-NexGard-Plus1
Join this discussion
Add your reply
Share a professional insight, ask a focused question, or add relevant clinical experience.
Member participation
Log in to join the discussion
Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.